Skip to main content
. 2012 Aug 12;2(8):788–800. doi: 10.7150/thno.4717

Table 1.

Clinical characteristics of the study population.

Characteristics Group (a) (n=9) Group (b) (n=40) Group (c) (n=50) P value
Male gender, n (%) 8 (88.9) 37 (94.9) 46 (92) 0.78
Age (years) 55.4±4.3 53.8±3.2 54.2±3.8 0.82
Body mass index (kg/m2) 25±5 26±6 26±5 0.87
Hypertension n (%) 3 (33.3) 15 (38.5) 18 (36) 0.95
Hyperlipidemia n (%) 3 (33.3) 11 (28.2) 15 (30) 0.95
Diabetes mellitus n (%) 2 (22.2) 10 (25.6) 13 (26) 0.97
Current smoker n (%) 6 (66.7) 28 (71.8) 34 (68) 0.91
UN(mmol/L) 4.1±0.4 4.2±0.5 4.6±0.3 0.72
Cr(μmol/L) 55.3±4.7 56.9±4.1 57.8±3.6 0.83
Cardiovascular history n (%)
Previous MI/ACS 6 25 33 0.98
Previous PCI 5 20 26 0.97
Medication
Aspirin(%) 8 (88.9) 34 (87.1) 43 (86) 0.97
clopidogrel(%) 6 (66.7) 27 (69.2) 37 (74) 0.84
ACEI/ARB(%) 7 (77.8) 30 (76.9) 41 (82) 0.83
β-blocher(%) 6 (66.7) 28 (71.8) 37 (74) 0.90
Statin(%) 7 (77.8) 33 (84.6) 43 (86) 0.82
Computed tomography coronary angiography
Length of the occlusion (mm) 0.8±0.5 1.1±0.6 1.7±0.8 <0.001
Severe calcification present 0 (0) 3 (7.5) 5 (10) <0.001
Length of calcification (mm) 0 1.2±0.5 1.1±0.6 <0.001
Collateralization present 7 (77.8) 33 (82.5) 37 (74) 0.628

Values are presented as mean ± SEM or number or proportion.